Stephanie Choi

Stephanie Choi is a seasoned professional with extensive experience in regulatory affairs and scientific policy within the pharmaceutical industry. Currently serving as Scientific Director at EMD Serono, Inc., since November 2021, Stephanie Choi develops initiatives related to oncology and biosimilars while engaging with stakeholders and health authorities. Previous roles include Associate Director positions at Jazz Pharmaceuticals and GW Pharmaceuticals, where Stephanie Choi focused on global regulatory strategies for early-stage drug development. Stephanie Choi's career began at the FDA, spanning over 12 years, where responsibilities included oversight of the generic drug research program, development of regulatory science, and collaboration with industry and academia. Stephanie Choi holds a Ph.D. in Chemical Engineering from the University of Maryland and a B.S. in Chemical Engineering from The Johns Hopkins University.